ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 176 filers reported holding ANTARES PHARMA INC in Q2 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $211,000 | +15.3% | 51,395 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $183,000 | +346.3% | 51,395 | +356.6% | 0.00% | – |
| Q3 2021 | $41,000 | -16.3% | 11,255 | 0.0% | 0.00% | – |
| Q2 2021 | $49,000 | +6.5% | 11,255 | 0.0% | 0.00% | – |
| Q1 2021 | $46,000 | +2.2% | 11,255 | 0.0% | 0.00% | – |
| Q4 2020 | $45,000 | +50.0% | 11,255 | 0.0% | 0.00% | – |
| Q3 2020 | $30,000 | -3.2% | 11,255 | 0.0% | 0.00% | – |
| Q2 2020 | $31,000 | +14.8% | 11,255 | 0.0% | 0.00% | – |
| Q1 2020 | $27,000 | -49.1% | 11,255 | 0.0% | 0.00% | – |
| Q4 2019 | $53,000 | +39.5% | 11,255 | 0.0% | 0.00% | – |
| Q3 2019 | $38,000 | +2.7% | 11,255 | 0.0% | 0.00% | – |
| Q2 2019 | $37,000 | +8.8% | 11,255 | 0.0% | 0.00% | – |
| Q1 2019 | $34,000 | +9.7% | 11,255 | 0.0% | 0.00% | – |
| Q4 2018 | $31,000 | – | 11,255 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
| Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
| Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
| PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
| Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
| Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
| Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
| Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |